Viewing Study NCT01517802

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:45 AM
Ignite Modification Date: 2026-02-20 @ 10:24 PM
Study NCT ID: NCT01517802
Status: COMPLETED
Last Update Posted: 2022-05-10
First Post: 2012-01-23
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: A Study That Provides Long-term Safety Follow-up and Examines Long-term Exposure to Abiraterone Acetate
Sponsor: Janssen Research & Development, LLC
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Castration-resistant Prostate Cancer View
None Metastatic Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Metastatic castration-resistant prostate cancer View
None Metastatic breast cancer View
None Abiraterone acetate View
None Low-dose corticosteroid treatment View
None Long-term access View